Hyundai Motor Co.'s ambitious plan of catching up with Tesla in electric vehicles could fizzle out this year due to delayed production, drying-up state subsidies, and a labor union's opposition to its massive investment in the US.
The South Korean automaker has received about 43,000 preorders for the Ioniq 5 since Feb. 25 but just 114 units were delivered in the first month of its domestic launch in April.
Hyundai planned to build 10,000 units last month but rolled out only 2,600 units as production at its Ulsan line was suspended for a week in early April due to a lack of traction motors.
The parts supply compounded Hyundai's woes as it was forced to halt production earlier this year due to the global semiconductor shortage.
To reduce the waiting time, Hyundai is offering units at a price discount that are without some advanced features like a parking assist or a rear-seat reminder system. It was also considering other options to retain customers who had placed orders.
A Hyundai Motor spokesperson said they cannot predict the delivery period for the Ioniq 5 at this point due to uncertainty over the parts supply.
The slower-than-expected EV rollout also raised concerns that Hyundai may not be eligible for central and provincial governments' subsidies allocated for this year.
The central government provides an 8 million won subsidy for each buyer while provincial governments allocate as much as 11 million won.


Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Fed Minutes Signal Rate Hikes Remain Possible as Inflation Risks Persist
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Gold Prices Slide as Treasury Yields Surge, Fed Minutes in Focus
REPAY Stock Rises After Visa Platform Connect Collaboration
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
OpenAI Tightens AI Safety Monitoring After Security Incidents
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Asian Stocks Slide as Chip Selloff and High Bond Yields Hit Markets
U.S. Public Debt Tops $40 Trillion for First Time
Wall Street Slides as Treasury Yields Surge to 19-Year High
China Set to Hold Benchmark Lending Rates Steady for 15th Month
Asian Currencies Rise as Dollar Hovers Near Multi-Month Lows
Trump Pauses 50% Canada Tariffs for Three Days as U.S. Trade Deal Takes Shape 



